Records containing: Resectable Pancreatic Ductal Adenocarcinoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-10-29Phase 1b Window-of-Opportunity Study Evaluating CDK7 Inhibition in Patients With Localized Basal Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-10-29SMART-PANC: SMAD4 Tailored Neoadjuvant Therapy for Pancreatic Cancer, A Phase ll Non-Randomized, Single Center Pilot Study
-
CLINICAL_TRIALS study record update · 2026-10-27Daraxonrasib in Resectable Pancreatic Ductal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-09-16Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-09-04A Window of Opportunity Strategy for Targeted Pathway Inhibition in Patients With Pancreatic Ductal Adenocarcinoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-15PIONEER-Panc: Phase II Investigations of New and Emerging Therapies for Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2026-03-20Phase I Study of NBTXR3 Activated by Radiotherapy for Locally Advanced or Borderline Resectable Pancreatic Ductal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-02-27A Window of Opportunity Strategy for Targeted Pathway Inhibition in Patients With Pancreatic Ductal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2026-01-16Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer
-
CLINICAL_TRIALS study record update · 2025-10-02Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
-
CLINICAL_TRIALS study record update · 2025-08-01Determining the Link Between Dietary Patterns, Fecal Microbiome and Response to Neoadjuvant Chemotherapy in Pancreatic Ductal Adenocarcinoma Patients
-
CLINICAL_TRIALS study record update · 2025-07-15A Phase I Dose Escalation Study Using Pyrvinium Pamoate Targeting HuR in Pancreatic Ductal Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2024-09-19Recurrent Disease Detection After Resection of Pancreatic Adenocarcinoma Using a Standardized Surveillance Strategy: a Nationwide Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2024-08-09A Pilot and Feasibility Study of PD-1 Blockade With Nivolumab in Combination With Chemotherapy in Patients With Borderline Resectable Pancreatic Adenocarcinoma
-
CLINICAL_TRIALS study record update · 2022-08-02A Phase II Trial to Assess the Evolution of KRAS Mutation Load by Liquid Biopsy in Patients With Resectable Pancreatic Ductal Adenocarcinoma Treated With Neoadjuvant NALIRINOX
-
CLINICAL_TRIALS study record update · 2020-01-31A Phase II Study of Neoadjuvant FOLFIRINOX in Patients With Resectable Pancreatic Ductal Adenocarcinoma With Tissue Collection
-
CLINICAL_TRIALS study record update · 2018-01-18The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma